novel coronavirus | sciencenewsnet.in

Forty studies later, a Keck Medicine of USC radiologist reveals what he has learned about COVID-19

October 28, 2020 sarah Jonas COVID-19, Lung Scarring, novel coronavirus, Radiology

Ali Gholamrezanezhad, MD, a clinical emergency radiologist with Keck Medicine of USC, was one of the first researchers to study COVID-19 in early 2020. Today, Gholamrezanezhad has co-authored more than 40 papers on the disease, gathering and analyzing a wide array of data and patient scans. He offers his unique insights into a virus that has infected more than 43 million people worldwide.

Research Results

UC San Diego Joins Second Major National Clinical Trial for Novel Coronavirus

September 2, 2020 sarah Jonas Clinical Trials, COVID-19, Immunology, Infectious Disease, novel coronavirus, Operation warp speed, Public Health, SARS-CoV-2, Vaccines

UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.

Announcement

Thomas Jefferson University Awarded $508,000 by the Commonwealth to support CoraVax™, a patented COVID-19 vaccine

August 28, 2020 sarah Jonas covid 19, novel coronavirus, Vaccine

Thomas Jefferson University Awarded $508,000 by the Commonwealth to support CoraVax™, a patented COVID-19 vaccine

Research Results

Is COVID-19 Transmitted Through Breast Milk? Study Suggests Not Likely

August 19, 2020 sarah Jonas Breast Milk, Breastfeeding, COVID-19, Infectious Disease, novel coronavirus, OB GYN, Pediatrics, Pregnancy and Childbirth, Public Health, SARS-CoV-2

A recent study by researchers at University of California San Diego School of Medicine suggests transmission of COVID-19 through breast milk is not likely. The infectious virus was not detected in 64 samples of breast milk tested.

Feature

Imitation May Be a Sincere Form of Treatment

August 5, 2020 sarah Jonas COVID-19, Covid-19 Clinical Trial, Infectious Disease, Monoclonal Antibodies, novel coronavirus, Public Health, SARS-CoV-2

The National Institutes of Health will soon launch a phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.

Announcement

ACTG Announces Launch of Novel Clinical Trial Testing Multiple Therapeutics to Treat COVID-19

August 4, 2020 sarah Jonas Coronavirus, COVID-19, novel coronavirus, Therapeutics, Therapy, Treatments, Trial

The AIDS Clinical Trials Group (ACTG) has initiated the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 evaluations of multiple promising investigational agents for treating early COVID-19 in a single trial.

Feature Expert

DePaul University researchers address COVID-19 challenges

July 22, 2020 sarah Jonas Coronavirus, COVID-19, COVID-19 pandemic, novel coronavirus, Research

In response to the COVID-19 pandemic, DePaul University has called on its scientific community to address challenges in the areas of disease dynamics, health diagnostics, security, preparation for testing, and clinical care related to the outbreak.

Expert Pitch

Abated Breath: From COVID-19 to Wildfire Smoke and Air Pollution, Multiple Factors Threaten Lung Health This Summer

July 22, 2020 sarah Jonas Air Quality and Health, Asthma, COPD, COVID-19, Infectious Disease, Lung Health, novel coronavirus, Public Health, pulmonary and critical care medicine, Pulmonary Medicine, Pulmonology, SARS-CoV-2, Wildfires

As we continue to grapple with the global pandemic, rising summer temperatures and wildfire season pose new challenges to our

Research Results

Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus?

July 9, 2020 sarah Jonas Blood Donation, blood plasma, Clinical Trials, COVID-19, Infectious Diseases, novel coronavirus, Public Health, SARS-CoV-2

Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.

Expert Pitch

UC San Diego Health (@UCSDHealth) Reproductive Expert Talks about COVID-19 and Fertility

July 1, 2020 sarah Jonas Coronavirus, COVID-19, Fertility, Infectious Disease, Infertility, novel coronavirus, Obstetrics, Pandemic, pregnancy and covid, Public Health, Reproductive Medicine, reproductive urology, SARS-CoV-2, Urology

During the novel coronavirus pandemic, many couples have concerns about reproductive consequences related to COVID-19. Experts say when it comes

Research Results

X-rays size up protein structure at the ‘heart’ of COVID-19 virus

June 25, 2020 sarah Jonas COVID-19, High Flux Isotope Reactor, Neutrons, novel coronavirus, Protease, SARS-CoV-2, Spallation Neutron Source, Summit supercomputer, Supercomputing and high-performance computing, X-rays

Researchers have performed the first room temperature X-ray measurements on the SARS-CoV-2 main protease—the enzyme that enables the virus to reproduce. It marks an important first step in the ultimate goal of building a comprehensive 3D model of the enzymatic protein that will be used to advance supercomputing simulations aimed at finding drug inhibitors to block the virus’s replication mechanism and help end the COVID-19 pandemic.

Research Results

Researchers Develop First Model to Predict Likelihood of Testing Positive for COVID-19 and Outcomes from the Disease

June 15, 2020 sarah Jonas Coronavirus, COVID-19, Melatonin, novel coronavirus

Cleveland Clinic researchers have developed the world’s first risk prediction model for healthcare providers to forecast an individual patient’s likelihood of testing positive for COVID-19 as well as their outcomes from the disease.

According a new study published in CHEST, the risk prediction model (called a nomogram) shows the relevance of age, race, gender, socioeconomic status, vaccination history and current medications in COVID-19 risk.

← Previous